ロード中...
The Pharmacological Burden of Comorbidities in Acromegaly
Background: Acromegaly is characterized by excess GH and elevated IGF-I often treated by surgery, pharmacotherapy (somatostatin analogs, GH receptor antagonists, dopamine agonists) and/or radiotherapy.(1) Common associated comorbidities include cardiovascular disorders and hypopituitarism, often req...
保存先:
| 出版年: | J Endocr Soc |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8090600/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.1324 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|